These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36470475)
1. Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients. Berg HE; Peterson JF; Lee HE; McPhail ED Hum Pathol; 2023 Jan; 131():108-115. PubMed ID: 36470475 [TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients. Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651 [TBL] [Abstract][Full Text] [Related]
3. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of 'double-hit' and 'double-expression' lymphomas. Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842 [TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. Frauenfeld L; Castrejon-de-Anta N; Ramis-Zaldivar JE; Streich S; Salmerón-Villalobos J; Otto F; Mayer AK; Steinhilber J; Pinyol M; Mankel B; Ramsower C; Bonzheim I; Fend F; Rimsza LM; Salaverria I; Campo E; Balagué O; Quintanilla-Martinez L Blood Adv; 2022 Apr; 6(7):2361-2372. PubMed ID: 34654055 [TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907 [No Abstract] [Full Text] [Related]
7. [Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement]. Luo D; Xiang CX; Ma DS; Liu GZ; Fan MT; Wang YB; Zhao J; Yuan YQ; Shen QQ; Liu XY; Liu H Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):563-569. PubMed ID: 38825901 [No Abstract] [Full Text] [Related]
8. Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population. Hesius EAM; van Laar L; Oosterveld M; van Spriel AB; Scheijen B; Leeuwis JW; Marres HAM; Groenen PJTA; Stevens WBC; van der Spek E; van den Brule AJC; Hoevenaars BM; Hebeda KM; van den Brand M Histopathology; 2023 Jun; 82(7):1013-1020. PubMed ID: 36779226 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma. Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646 [TBL] [Abstract][Full Text] [Related]
10. High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs. Marino FZ; Aquino G; Brunelli M; Scognamiglio G; Pedron S; Ronchi A; Cozzolino I; Sparano L; Botti G; Panico L; De Chiara A; Franco R; Virchows Arch; 2021 Sep; 479(3):565-573. PubMed ID: 33768318 [TBL] [Abstract][Full Text] [Related]
11. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma. Cho YA; Hyeon J; Lee H; Cho J; Kim SJ; Kim WS; Ko YH Hum Pathol; 2021 Jul; 113():9-19. PubMed ID: 33771538 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases]. Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172 [No Abstract] [Full Text] [Related]
13. Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups? Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults. Streich S; Frauenfeld L; Otto F; Mankel B; Bonzheim I; Fend F; Quintanilla-Martinez L Virchows Arch; 2023 Mar; 482(3):551-560. PubMed ID: 36810796 [TBL] [Abstract][Full Text] [Related]
15. Tourneret A; Alame M; Rigau V; Bauchet L; Fabbro M; De Oliveira L; Cacheux V; Costes V; Lacheretz-Szablewski V J Clin Pathol; 2021 Oct; 74(10):650-656. PubMed ID: 32912960 [TBL] [Abstract][Full Text] [Related]
16. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases. Wang W; Hu S; Lu X; Young KH; Medeiros LJ Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391 [TBL] [Abstract][Full Text] [Related]
18. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type. Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208 [TBL] [Abstract][Full Text] [Related]
19. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas]. Gerhard-Hartmann E; Rosenwald A Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092 [TBL] [Abstract][Full Text] [Related]
20. Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity. Bhavsar S; Liu YC; Gibson SE; Moore EM; Swerdlow SH Am J Surg Pathol; 2022 Jan; 46(1):71-82. PubMed ID: 34392269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]